SCHEMBL10328514

SCHEMBL10328514

Cc1cc(Cc2ccc(NS(=O)(=O)c3cccc(C#N)c3)c(F)c2)c2cc(F)ccc2n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACLY P53396 2/20 0.45
▸ GLO1 Q04760 1/20 0.41
▸ SLC40A1 Q9NP59 1/20 0.41
▸ CRBN Q96SW2 1/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.40
▸ BRAF P15056 2/20 0.39
▸ MAP3K20 Q9NYL2 2/20 0.39
▸ KIT P10721 2/20 0.39
▸ FRK P42685 1/20 0.39
▸ SIK1 P57059 1/20 0.39
▸ MAP2K5 Q13163 1/20 0.39
▸ AURKB Q96GD4 1/20 0.39
▸ SRMS Q9H3Y6 1/20 0.39
▸ PGR P06401 1/20 0.39
▸ MAP2K4 P45985 1/20 0.38
▸ TRIM24 O15164 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ SGK1 O00141 1/20 0.37
▸ CCR1 P32246 1/20 0.37
▸ CCR2 P41597 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10328531 0.85 KEAP1 (0.47) GLO1SLC40A1BRAFMAP3K20KIT
SCHEMBL10328535 0.85 AXL (0.45) ACLYSLC40A1KITPGRCCR1
SCHEMBL10328534 0.82 AGTR1 (0.44) ACLYMAPTCCR1CCR2CCR4
SCHEMBL1591689 0.81 AXL (0.53) ACLYGLO1SLC40A1CRBNPGR
SCHEMBL10328495 0.79 TP53 (0.43) MAPTCCR2
SCHEMBL10328491 0.77 AXL (0.55) ACLYGLO1SLC40A1BRAFMAP3K20
SCHEMBL10328523 0.75 PGR (0.47) PGRMAP2K4MAPTPTPN2PTPN1
SCHEMBL10320336 0.72 AXL (0.47) ACLYPGRTRIM24PIK3CDGPR119
SCHEMBL13667269 0.69 RORC (0.52) KIT
SCHEMBL10328532 0.68 NR1H2 (0.45) ACLYGLO1SLC40A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2262772-B1 QUINOLINE DERIVATIVES AS AXL KINASE INHIBITORS MAX PLANCK GESELLSCHAFT (DE) 2012-07-18 — — EP disclosed
Send feedback